ARCHIVES

FDA Approves Genetic Test For Breast Cancer Patients

This article is from The Cancer Letter archive.

Vol. 31 No. 1 | January 25, 2008

Download PDF Visit The Full Archive

Related Articles

FDA Staff Failed To Explain Approval Standards, Correct Misconceptions.

April 13, 2007

FDA approves a new cancer drug, Vidaza, and two sNDAs, without going to ODAC. A date with ODAC may signal a weak case for drug approval, recent approval data indicate.

May 28, 2004

Preventive Surgery Cuts Risk Of Breast, Ovarian Cancers

May 31, 2002

Also in this 8-page issue: NIH opens 240-bed Hatfield Clinical Research Center.

September 24, 2004

The Cancer Letter Wins Investigative Reporting Award

June 8, 2001

AACR Honors Nine Cancer Researchers, Clinicians.

March 31, 2000